Neuropsychology
Utilizing intraindividual cognitive variability to predict progression in stage 2 neuronal synuclein disease
By Hannah L. Combs, Parkinson's Progression Markers Initiative, Ryan Kurth, Show 4 more authorsChelsea Caspell-Garcia
Study in peopleBiomarkers
The paper
Baylor College of Medicine; University of Iowa
Neuropsychology, 10 Sep 2026
